FDA Authority To Force Antihistamine Switch Denounced By Pfizer Chief
This article was originally published in The Tan Sheet
Executive Summary
FDA lacks the statutory power to force a prescription antihistamine to switch OTC, Pfizer CEO Henry McKinnell insisted during an analysts call April 18.